In the ongoing context of the Covid-19 pandemic, our board member, Pranjal Sharma, wrote the following OpEd, published by The Daily Guardian, on the benefits of waivering the IPR (intellectual property rights) on vaccine production, particularly for low-income countries such as India and those of the African continent.

Read his tribune here: https://thedailyguardian.com/profiteering-pandemic-wto-pharma-industry-must-introspect/